JP2016135810A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016135810A5 JP2016135810A5 JP2016086986A JP2016086986A JP2016135810A5 JP 2016135810 A5 JP2016135810 A5 JP 2016135810A5 JP 2016086986 A JP2016086986 A JP 2016086986A JP 2016086986 A JP2016086986 A JP 2016086986A JP 2016135810 A5 JP2016135810 A5 JP 2016135810A5
- Authority
- JP
- Japan
- Prior art keywords
- concentration
- latanoprost
- inclusive
- fatty acid
- acid ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 29
- GGXICVAJURFBLW-CEYXHVGTSA-N latanoprost Chemical compound CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1 GGXICVAJURFBLW-CEYXHVGTSA-N 0.000 claims 13
- 229960001160 latanoprost Drugs 0.000 claims 13
- 235000014113 dietary fatty acids Nutrition 0.000 claims 11
- 229930195729 fatty acid Natural products 0.000 claims 11
- 239000000194 fatty acid Substances 0.000 claims 11
- -1 fatty acid ester Chemical class 0.000 claims 11
- 239000000203 mixture Substances 0.000 claims 11
- 239000003883 ointment base Substances 0.000 claims 9
- 210000000577 adipose tissue Anatomy 0.000 claims 2
- 210000000038 chest Anatomy 0.000 claims 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical group CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 claims 2
- 239000003755 preservative agent Substances 0.000 claims 2
- 230000002335 preservative effect Effects 0.000 claims 2
- 210000001015 abdomen Anatomy 0.000 claims 1
- 210000001217 buttock Anatomy 0.000 claims 1
- 229960004926 chlorobutanol Drugs 0.000 claims 1
- 210000000744 eyelid Anatomy 0.000 claims 1
- 210000004392 genitalia Anatomy 0.000 claims 1
- 210000001624 hip Anatomy 0.000 claims 1
- 210000003127 knee Anatomy 0.000 claims 1
- 210000002414 leg Anatomy 0.000 claims 1
- 210000004003 subcutaneous fat Anatomy 0.000 claims 1
- 210000000689 upper leg Anatomy 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361822139P | 2013-05-10 | 2013-05-10 | |
| US61/822,139 | 2013-05-10 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016513124A Division JP5930568B1 (ja) | 2013-05-10 | 2014-05-09 | プロスタグランジンの皮下脂肪への局所送達のための組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016135810A JP2016135810A (ja) | 2016-07-28 |
| JP2016135810A5 true JP2016135810A5 (enExample) | 2017-06-22 |
Family
ID=50933526
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016513124A Expired - Fee Related JP5930568B1 (ja) | 2013-05-10 | 2014-05-09 | プロスタグランジンの皮下脂肪への局所送達のための組成物および方法 |
| JP2016086986A Pending JP2016135810A (ja) | 2013-05-10 | 2016-04-25 | プロスタグランジンの皮下脂肪への局所送達のための組成物および方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016513124A Expired - Fee Related JP5930568B1 (ja) | 2013-05-10 | 2014-05-09 | プロスタグランジンの皮下脂肪への局所送達のための組成物および方法 |
Country Status (27)
| Country | Link |
|---|---|
| US (5) | US9040584B2 (enExample) |
| EP (3) | EP2863886B1 (enExample) |
| JP (2) | JP5930568B1 (enExample) |
| KR (4) | KR20210040180A (enExample) |
| CN (2) | CN105209015B (enExample) |
| AU (3) | AU2014262495B9 (enExample) |
| BR (1) | BR112015028290A2 (enExample) |
| CA (1) | CA2907721C (enExample) |
| CL (1) | CL2015003270A1 (enExample) |
| CR (1) | CR20150652A (enExample) |
| CY (1) | CY1118654T1 (enExample) |
| DK (2) | DK3124015T3 (enExample) |
| ES (2) | ES2670323T3 (enExample) |
| HU (2) | HUE030977T2 (enExample) |
| IL (2) | IL240807A (enExample) |
| MX (2) | MX347969B (enExample) |
| MY (1) | MY183193A (enExample) |
| NO (1) | NO2753788T3 (enExample) |
| NZ (1) | NZ712784A (enExample) |
| PH (1) | PH12015502503B1 (enExample) |
| PL (2) | PL2863886T3 (enExample) |
| PT (2) | PT3124015T (enExample) |
| RU (1) | RU2635864C2 (enExample) |
| SG (2) | SG11201600068WA (enExample) |
| SI (1) | SI2863886T1 (enExample) |
| WO (1) | WO2014183045A2 (enExample) |
| ZA (1) | ZA201507702B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7666912B2 (en) | 2006-03-23 | 2010-02-23 | Massachusetts Eye And Ear Infirmary | Compositions and methods for reducing body fat |
| KR20170095402A (ko) | 2009-11-09 | 2017-08-22 | 알러간, 인코포레이티드 | 모발 성장을 촉진하기 위한 조성물 및 방법 |
| CA2866067C (en) | 2011-01-19 | 2015-04-21 | Topokine Therapeutics, Inc. | Uses of certain f-series prostaglandin analogs for treating diabetes and dyslipidemia |
| US8426471B1 (en) | 2011-12-19 | 2013-04-23 | Topokine Therapeutics, Inc. | Methods and compositions for reducing body fat and adipocytes |
| NO2753788T3 (enExample) * | 2013-05-10 | 2018-06-16 | ||
| US9820993B2 (en) | 2013-05-15 | 2017-11-21 | Topokine Therapeutics, Inc. | Methods and compositions for topical delivery of prostaglandins to subcutaneous fat |
| US10188661B2 (en) | 2014-06-27 | 2019-01-29 | Topokine Therapeutics, Inc. | Topical dosage regimen |
| CA2983942A1 (en) * | 2015-04-30 | 2016-11-03 | Allergan, Inc. | Cosmetic method and therapeutic use for fat reduction |
| CA2988908A1 (en) * | 2015-06-09 | 2016-12-15 | Thesan Pharmaceuticals, Inc. | Beta-naphthoisoflavones, compositions containing, and uses of, same |
| US20180179174A1 (en) * | 2015-06-23 | 2018-06-28 | Thesan Pharmaceuticals, Inc. | 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME |
| US20180185325A1 (en) * | 2015-06-23 | 2018-07-05 | Thesan Pharmaceuticals, Inc. | 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME |
| US10674746B2 (en) | 2015-10-27 | 2020-06-09 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
| CN108473384A (zh) | 2015-10-27 | 2018-08-31 | 细胞酶动物营养品公司 | 动物营养成分及相关方法 |
| CN107773758B (zh) * | 2016-08-31 | 2021-02-26 | 程辉 | 一种用于消除皮下脂肪沉积的组合物及其应用 |
| EP4509118A3 (en) * | 2018-09-19 | 2025-05-14 | ModernaTX, Inc. | High-purity peg lipids and uses thereof |
| EP3713551B1 (en) | 2018-10-16 | 2023-06-07 | Polithera, Inc. | Alcohol-based compositions and uses thereof |
| PL427837A1 (pl) * | 2018-11-22 | 2020-06-01 | Gbj Pharma Spółka Z Ograniczoną Odpowiedzialnością | Systemy do ciągłego obwodowego podawania latanoprostu dla obniżania ciśnienia śródgałkowego |
| US20220273765A1 (en) * | 2019-04-24 | 2022-09-01 | Follicum Ab | Topical formulation |
| US11452703B2 (en) * | 2020-05-21 | 2022-09-27 | Peregrine Ophthalmic PTE LTD. | Methods and compositions for reducing adipocyte numbers |
| JP6855026B1 (ja) * | 2020-11-09 | 2021-04-07 | 東亜薬品株式会社 | タフルプロスト点眼液 |
| KR20240032924A (ko) * | 2021-07-12 | 2024-03-12 | 오큐소프트, 인코포레이티드 | 피부 보습 조성물 |
Family Cites Families (95)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4270537A (en) | 1979-11-19 | 1981-06-02 | Romaine Richard A | Automatic hypodermic syringe |
| US4599353A (en) | 1982-05-03 | 1986-07-08 | The Trustees Of Columbia University In The City Of New York | Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US4886499A (en) | 1986-12-18 | 1989-12-12 | Hoffmann-La Roche Inc. | Portable injection appliance |
| GB8704027D0 (en) | 1987-02-20 | 1987-03-25 | Owen Mumford Ltd | Syringe needle combination |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US4940460A (en) | 1987-06-19 | 1990-07-10 | Bioject, Inc. | Patient-fillable and non-invasive hypodermic injection device assembly |
| EP0302147A1 (en) | 1987-08-03 | 1989-02-08 | The Procter & Gamble Company | Topical tanning compositions |
| US5339163A (en) | 1988-03-16 | 1994-08-16 | Canon Kabushiki Kaisha | Automatic exposure control device using plural image plane detection areas |
| US5296504A (en) | 1988-09-06 | 1994-03-22 | Kabi Pharmacia | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| ATE420857T1 (de) | 1988-09-06 | 2009-01-15 | Pfizer Health Ab | Prostaglandin-derivate zur behandlung von glaukom und ocularer hypertension |
| FR2638359A1 (fr) | 1988-11-03 | 1990-05-04 | Tino Dalto | Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5011062A (en) | 1990-05-09 | 1991-04-30 | Delco Electronics Corporation | Ultrasonic welding mask |
| US5190521A (en) | 1990-08-22 | 1993-03-02 | Tecnol Medical Products, Inc. | Apparatus and method for raising a skin wheal and anesthetizing skin |
| US5527288A (en) | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
| GB9118204D0 (en) | 1991-08-23 | 1991-10-09 | Weston Terence E | Needle-less injector |
| SE9102652D0 (sv) | 1991-09-13 | 1991-09-13 | Kabi Pharmacia Ab | Injection needle arrangement |
| US5328483A (en) | 1992-02-27 | 1994-07-12 | Jacoby Richard M | Intradermal injection device with medication and needle guard |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| US5972991A (en) | 1992-09-21 | 1999-10-26 | Allergan | Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US5688819A (en) | 1992-09-21 | 1997-11-18 | Allergan | Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| US5569189A (en) | 1992-09-28 | 1996-10-29 | Equidyne Systems, Inc. | hypodermic jet injector |
| US5334144A (en) | 1992-10-30 | 1994-08-02 | Becton, Dickinson And Company | Single use disposable needleless injector |
| US5510383A (en) | 1993-08-03 | 1996-04-23 | Alcon Laboratories, Inc. | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
| JPH07138258A (ja) | 1993-11-16 | 1995-05-30 | Taiho Yakuhin Kogyo Kk | チアゾリジンジオン誘導体又はその塩 |
| US5380760A (en) * | 1993-11-19 | 1995-01-10 | Minnesota Mining And Manufacturing Company | Transdermal prostaglandin composition |
| WO1995024176A1 (en) | 1994-03-07 | 1995-09-14 | Bioject, Inc. | Ampule filling device |
| US5466220A (en) | 1994-03-08 | 1995-11-14 | Bioject, Inc. | Drug vial mixing and transfer device |
| US5631287A (en) | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
| US5599302A (en) | 1995-01-09 | 1997-02-04 | Medi-Ject Corporation | Medical injection system and method, gas spring thereof and launching device using gas spring |
| US5730723A (en) | 1995-10-10 | 1998-03-24 | Visionary Medical Products Corporation, Inc. | Gas pressured needle-less injection device and method |
| US5893397A (en) | 1996-01-12 | 1999-04-13 | Bioject Inc. | Medication vial/syringe liquid-transfer apparatus |
| GB9607549D0 (en) | 1996-04-11 | 1996-06-12 | Weston Medical Ltd | Spring-powered dispensing device |
| RU2157689C2 (ru) | 1996-07-24 | 2000-10-20 | Панацея Биотек Лтд. | Фармацевтические композиции терапевтического антивоспалительного и болеутоляющего средства для местного нанесения и способ их получения |
| JP3480549B2 (ja) | 1996-12-26 | 2003-12-22 | 参天製薬株式会社 | ジフルオロプロスタグランジン誘導体およびその用途 |
| AU750039B2 (en) | 1997-02-04 | 2002-07-11 | Murray A. Johnstone | Method of enhancing hair growth |
| US5993412A (en) | 1997-05-19 | 1999-11-30 | Bioject, Inc. | Injection apparatus |
| US6646001B2 (en) | 1997-12-19 | 2003-11-11 | Alcon Manufacturing, Ltd. | Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension |
| US6232344B1 (en) | 1997-12-22 | 2001-05-15 | Alcon Laboratories, Inc. | 13-Oxa prostaglandins for the treatment of glaucoma and ocular hypertension |
| IT1298087B1 (it) | 1998-01-08 | 1999-12-20 | Fiderm S R L | Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni |
| US6235781B1 (en) | 1998-07-14 | 2001-05-22 | Alcon Laboratories, Inc. | Prostaglandin product |
| ATE406914T1 (de) | 2000-02-10 | 2008-09-15 | Massachusetts Eye & Ear Infirm | Photodynamische therapie zur behandlung von augenerkrankungen |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| ES2172415B2 (es) | 2000-07-28 | 2003-11-16 | Univ Madrid Complutense | Tratamiento del glaucoma y la hipertension ocular por medio de un analogo de la melatonina. |
| EA006556B1 (ru) | 2001-03-27 | 2006-02-24 | Те Риджентс Оф Те Юниверсити Оф Калифорния | Способы, соединения и композиции для борьбы с ожирением и регулирования метаболизма жирных кислот |
| GB0202159D0 (en) | 2002-01-30 | 2002-03-20 | Sensor Highway Ltd | OPtical time domain reflectometry |
| IL147921A0 (en) | 2002-01-31 | 2002-08-14 | Abdulrazik Mohammad | A method for treating central nervous system disorders by ocular dosing |
| US7351404B2 (en) | 2002-02-04 | 2008-04-01 | Allergan, Inc. | Method of enhancing hair growth |
| JP4387639B2 (ja) * | 2002-07-16 | 2009-12-16 | 久光製薬株式会社 | 経皮吸収製剤 |
| US6864282B2 (en) | 2002-08-05 | 2005-03-08 | Allergan, Inc. | 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
| US20040115234A1 (en) | 2002-09-24 | 2004-06-17 | Gewirtz Joan T. | Cosmetic composition |
| US8114911B2 (en) | 2002-10-23 | 2012-02-14 | Sucampo Ag | Prostaglandin compounds for the treatment of obesity |
| US7074827B2 (en) | 2002-10-24 | 2006-07-11 | Sucampo Ag (Usa) Inc. | Method for treating ocular hypertension and glaucoma |
| AU2004224329B2 (en) | 2003-03-21 | 2009-07-09 | Nexmed (Holdings), Inc. | Compositions and methods for treatment of premature ejaculation |
| US6933289B2 (en) | 2003-07-01 | 2005-08-23 | Allergan, Inc. | Inhibition of irritating side effects associated with use of a topical ophthalmic medication |
| US20050058614A1 (en) | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods for the treatment of gray hair using cyclopentane(ene) heptan(en)oic acid amides |
| US7070768B2 (en) | 2003-09-25 | 2006-07-04 | Allergan, Inc. | Method for imparting artificial tan to human skin |
| US8722097B2 (en) | 2004-04-30 | 2014-05-13 | Allergan, Inc. | Oil-in-water method for making polymeric implants containing a hypotensive lipid |
| US7993634B2 (en) | 2004-04-30 | 2011-08-09 | Allergan, Inc. | Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods |
| PL2422789T3 (pl) | 2004-05-19 | 2018-09-28 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Wstrzykiwalna kompozycja zawierająca deoksycholan sodu |
| ATE412400T1 (de) | 2004-11-09 | 2008-11-15 | Novagali Pharma Sa | Öl-in-wasser-emulsion mit niedriger konzentration des kationischen mittels und positivem zetapotential |
| WO2006082588A2 (en) | 2005-02-07 | 2006-08-10 | Pharmalight Inc. | Method and device for ophthalmic administration of active pharmaceutical ingredients |
| CA2602573C (en) | 2005-03-31 | 2013-10-08 | Asahi Glass Co Ltd | Protective agent for retinal neuronal cell containing prostaglandin f2 .alpha. derivative as active ingredient |
| BRPI0613034A8 (pt) | 2005-07-14 | 2018-01-02 | Lipothera Inc | formulação injetável para acúmulo de tecido adiposo, formulação injetável e método para o tratamento de acúmulo de gordura, e, método para reduzir o tecido adiposo. |
| US20080205679A1 (en) * | 2005-07-18 | 2008-08-28 | Darbut Alexander L | In-Ear Auditory Device and Methods of Using Same |
| WO2007026356A2 (en) | 2005-08-29 | 2007-03-08 | Healor Ltd. | Methods and compositions for prevention and treatment of diabetic and aged skin |
| US9393218B2 (en) | 2005-12-23 | 2016-07-19 | Epinamics Gmbh | Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers |
| US7666912B2 (en) * | 2006-03-23 | 2010-02-23 | Massachusetts Eye And Ear Infirmary | Compositions and methods for reducing body fat |
| RU2325912C1 (ru) * | 2006-09-06 | 2008-06-10 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтическая композиция противовоспалительного и антимикробного действия в форме мази на гидрофобной основе для лечения кожных заболеваний (варианты) |
| US8796282B2 (en) | 2007-03-28 | 2014-08-05 | Case Western Reserve University | Method of treating dermatological disorders |
| WO2008120249A1 (en) | 2007-03-30 | 2008-10-09 | Sifi S.P.A. | Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use |
| US20100074857A1 (en) * | 2008-09-23 | 2010-03-25 | Pamela Lipkin | Compositions and methods to treat epithelial-related conditions |
| US20100104654A1 (en) | 2008-10-27 | 2010-04-29 | Allergan, Inc. | Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof |
| US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
| CN101427993A (zh) | 2008-11-20 | 2009-05-13 | 沈阳万爱普利德医药科技有限公司 | 前列腺素微乳凝胶制剂及其制备方法 |
| EP2228058A1 (en) * | 2009-03-04 | 2010-09-15 | Novagali Pharma S.A. | Anionic oil-in-water emulsion containing prostaglandins and uses thereof |
| KR20170095402A (ko) | 2009-11-09 | 2017-08-22 | 알러간, 인코포레이티드 | 모발 성장을 촉진하기 위한 조성물 및 방법 |
| EP2389939A1 (en) * | 2010-05-28 | 2011-11-30 | Novagali Pharma S.A. | Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions |
| US20120129789A1 (en) * | 2010-11-18 | 2012-05-24 | Steven Yoelin | Compositions and methods for hair growth |
| CA2866067C (en) | 2011-01-19 | 2015-04-21 | Topokine Therapeutics, Inc. | Uses of certain f-series prostaglandin analogs for treating diabetes and dyslipidemia |
| BR112013020719B1 (pt) | 2011-02-14 | 2018-04-17 | Allergan, Inc. | Composições de derivados de bimatoprost tipo éster e métodos |
| US20120251613A1 (en) * | 2011-03-29 | 2012-10-04 | Agila Specialities Pvt. Ltd. | Method for treating vitiligo with a prostaglandin analogue |
| JP2012250950A (ja) * | 2011-06-06 | 2012-12-20 | Santen Pharmaceut Co Ltd | アデノシン誘導体とプロスタグランジン類の組合せ剤 |
| JP2014520895A (ja) * | 2011-07-20 | 2014-08-25 | アラーガン インコーポレイテッド | ビマトプロストおよびブリモニジンの固定用量の組み合わせ |
| US20130035338A1 (en) * | 2011-08-05 | 2013-02-07 | Gordon Tang | Eyelid treatment |
| US8426471B1 (en) | 2011-12-19 | 2013-04-23 | Topokine Therapeutics, Inc. | Methods and compositions for reducing body fat and adipocytes |
| US20150164765A1 (en) | 2012-05-17 | 2015-06-18 | Steven G. Yoelin | Compositions and methods for hair growth |
| KR20140043562A (ko) | 2012-09-24 | 2014-04-10 | 한국콜마주식회사 | 무복계면 라타노프로스트 및 그 제조방법 |
| WO2014081941A1 (en) | 2012-11-21 | 2014-05-30 | Topokine Therapeutics, Inc. | Methods and compositions for locally increasing body fat |
| NO2753788T3 (enExample) | 2013-05-10 | 2018-06-16 | ||
| US9820993B2 (en) * | 2013-05-15 | 2017-11-21 | Topokine Therapeutics, Inc. | Methods and compositions for topical delivery of prostaglandins to subcutaneous fat |
| US10188661B2 (en) | 2014-06-27 | 2019-01-29 | Topokine Therapeutics, Inc. | Topical dosage regimen |
-
2012
- 2012-04-05 NO NO12829698A patent/NO2753788T3/no unknown
-
2014
- 2014-05-09 AU AU2014262495A patent/AU2014262495B9/en not_active Ceased
- 2014-05-09 HU HUE14729803A patent/HUE030977T2/en unknown
- 2014-05-09 PL PL14729803T patent/PL2863886T3/pl unknown
- 2014-05-09 EP EP14729803.8A patent/EP2863886B1/en active Active
- 2014-05-09 KR KR1020217009848A patent/KR20210040180A/ko not_active Ceased
- 2014-05-09 SG SG11201600068WA patent/SG11201600068WA/en unknown
- 2014-05-09 KR KR1020167022712A patent/KR102098987B1/ko not_active Expired - Fee Related
- 2014-05-09 MY MYPI2015703803A patent/MY183193A/en unknown
- 2014-05-09 DK DK16177742.0T patent/DK3124015T3/en active
- 2014-05-09 HU HUE16177742A patent/HUE037405T2/hu unknown
- 2014-05-09 CN CN201480027172.6A patent/CN105209015B/zh not_active Expired - Fee Related
- 2014-05-09 WO PCT/US2014/037512 patent/WO2014183045A2/en not_active Ceased
- 2014-05-09 SG SG10201604659QA patent/SG10201604659QA/en unknown
- 2014-05-09 PT PT161777420T patent/PT3124015T/pt unknown
- 2014-05-09 KR KR1020157032864A patent/KR101651450B1/ko not_active Expired - Fee Related
- 2014-05-09 SI SI201430090A patent/SI2863886T1/sl unknown
- 2014-05-09 ES ES16177742.0T patent/ES2670323T3/es active Active
- 2014-05-09 KR KR1020207009488A patent/KR20200037458A/ko not_active Ceased
- 2014-05-09 NZ NZ712784A patent/NZ712784A/en not_active IP Right Cessation
- 2014-05-09 MX MX2015015535A patent/MX347969B/es active IP Right Grant
- 2014-05-09 BR BR112015028290A patent/BR112015028290A2/pt active Search and Examination
- 2014-05-09 CA CA2907721A patent/CA2907721C/en active Active
- 2014-05-09 EP EP18162319.0A patent/EP3395328A1/en not_active Withdrawn
- 2014-05-09 JP JP2016513124A patent/JP5930568B1/ja not_active Expired - Fee Related
- 2014-05-09 DK DK14729803.8T patent/DK2863886T3/en active
- 2014-05-09 PL PL16177742T patent/PL3124015T3/pl unknown
- 2014-05-09 PT PT147298038T patent/PT2863886T/pt unknown
- 2014-05-09 EP EP16177742.0A patent/EP3124015B1/en not_active Not-in-force
- 2014-05-09 RU RU2015141767A patent/RU2635864C2/ru active
- 2014-05-09 CN CN201811245298.7A patent/CN109966240A/zh active Pending
- 2014-05-09 ES ES14729803.8T patent/ES2604160T3/es active Active
- 2014-12-18 US US14/575,873 patent/US9040584B2/en active Active
-
2015
- 2015-05-01 US US14/702,365 patent/US9849179B2/en active Active
- 2015-08-25 IL IL240807A patent/IL240807A/en active IP Right Grant
- 2015-10-14 ZA ZA2015/07702A patent/ZA201507702B/en unknown
- 2015-10-30 PH PH12015502503A patent/PH12015502503B1/en unknown
- 2015-11-06 CL CL2015003270A patent/CL2015003270A1/es unknown
- 2015-11-09 MX MX2020002881A patent/MX2020002881A/es unknown
- 2015-12-10 CR CR20150652A patent/CR20150652A/es unknown
-
2016
- 2016-04-25 JP JP2016086986A patent/JP2016135810A/ja active Pending
- 2016-11-23 CY CY20161101214T patent/CY1118654T1/el unknown
-
2017
- 2017-03-29 IL IL251448A patent/IL251448B/en active IP Right Grant
- 2017-12-15 US US15/843,272 patent/US10556012B2/en active Active
-
2019
- 2019-10-18 AU AU2019250230A patent/AU2019250230A1/en not_active Abandoned
-
2020
- 2020-02-10 US US16/785,892 patent/US20200282059A1/en not_active Abandoned
-
2021
- 2021-08-27 AU AU2021221900A patent/AU2021221900A1/en not_active Abandoned
- 2021-09-27 US US17/448,947 patent/US20220152206A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016135810A5 (enExample) | ||
| Mirtaleb et al. | Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy | |
| JP2016527307A5 (enExample) | ||
| RU2014150942A (ru) | Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона | |
| JP2016531949A5 (enExample) | ||
| MX2023012728A (es) | Esteroide neuroactivo para el tratamiento del trastorno depresivo mayor y la depresion posparto en una mujer lactante. | |
| FI3840753T3 (fi) | Migalastaatti käytettäväksi fabryn taudin hoitomenetelmissä potilailla joilla on gla-geenin mutaatio | |
| JP2017513824A5 (enExample) | ||
| JP2017523230A5 (enExample) | ||
| JOP20190019A1 (ar) | تركيبة صيدلانية لعلاج نقص في هرمون نمو يحتوي على بروتين اندماجي لهرمون نمو بشري (hGH) | |
| CA3168207A1 (en) | Cellular uptake | |
| CN113038920A (zh) | 用于治疗美学皮肤病症的铁螯合化合物 | |
| RU2017140078A (ru) | Косметический способ и его терапевтическое применение для уменьшения объема жировой ткани | |
| JP2013536169A5 (enExample) | ||
| WO2016029015A1 (en) | Transdermal pharmaceutical compositions including testosterone and an aromatase inhibitor | |
| MX2018013477A (es) | Acidos carboxilicos para tratar/prevenir una enfermedad de la piel. | |
| CA2364606C (en) | Oil-in-water emulsion for the use as medicament or for producing a medicament | |
| CN204972069U (zh) | 一种风湿病医用理疗床 | |
| CN208229090U (zh) | 一种带康复训练的多用途座椅 | |
| CN208259812U (zh) | 助力护腰带 | |
| MX2018013474A (es) | Acidos carboxilicos para aplicacion en la primera infancia. | |
| JP2012180331A (ja) | 筋損傷の早期回復の誘導用の経口摂取剤 | |
| MX2025010811A (es) | Un metodo para el tratamiento de eccema cronico de manos en pacientes con eccema cronico de manos de moderado a severo | |
| EA201891177A1 (ru) | Фармацевтическая композиция для лечения инфекционно-воспалительных заболеваний местного применения и способ ее получения и применения (варианты) | |
| CO2025007626A2 (es) | Composiciones farmacéuticas para administración ocular |